In the 1950s, thalidomide cut a wide swath of destruction across the world, leaving behind thousands of deformed infants, but that was only the beginning of the story.
Sign up for the Retro Report newsletter

Infamous Birth Defect Drug Thalidomide's Unlikely Comeback

Produced by Kit Roane

When it was introduced in Germany in the late 1950s, thalidomide was supposed to be something of a miracle drug: a completely safe sleeping pill that could also treat a range of ills. But after it spread across Europe and the rest of the world, this chemical farrago proved to be something far more sinister – a poison of a sort, one that caused an untold number of spontaneous abortions and led to thousands of terribly deformed infants.

The United States was largely spared this medical disaster thanks to the tenacity of one woman, a young FDA reviewer named Dr. Francis Kelsey, who fought more than a year to delay the drug’s approval in the United States and ultimately prevented its release. The realization of how close America came to participating in the tragedy sweeping across Europe brought about regulatory reforms that held pharmaceutical firms far more accountable for the drugs they make.

But, as Retro Report found, this dark chapter was not the end for thalidomide. Decades later scientific inquisitiveness collided with luck to turn the once-infamous drug into a life-saving treatment for tens of thousands of patients in the throes of other painful and often deadly diseases. From leprosy to blood-born cancers, thalidomide is now a go-to drug. This salvation, however, continues to carry a human cost; the shadow of its past is being revisited today in places like Brazil, and victims say they continue to look warily toward thalidomide’s future.

For more information on thalidomide:

The Thalidomide Trust

International Contergan Thalidomide Alliance

Thalidomide Victims Association of Canada

United States Food and Drug Administration

Transcript

More on the Story

Farewell to drug regulation? The Los Angeles Times
Trump’s F.D.A. Pick Could Undo Decades of Drug Safeguards The New York Times
Donald Trump’s possible pick for FDA chief wants drugmakers to sell first, then test later Salon
Frances Oldham Kelsey, F.D.A. Stickler Who Saved U.S. Babies From Thalidomide, Dies at 101 New York Times
NOMINEES FOR THE 34th ANNUAL NEWS & DOCUMENTARY EMMY® AWARDS The National Academy of Television Arts & Sciences
2014 GRACIES AWARDS WINNERS Alliance for Women in Media
Related Coverage
The Death and Afterlife of Thalidomide The New York Times
Retro Report Looks At the Afterlife of Thalidomide National Geographic
Kit Roane: “The Shadow of Thalidomide” Chris Riback's Conversations with Thinkers
The Shadow of the Thalidomide Tragedy Reddit